|
Type 2 diabetes
Citations 401-410 of 450 total displayed.
|
Past content
(since Jan 2001):
|
- Articles
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus. A Blood Pressure--Independent Effect
- Giancarlo Viberti, Nigel M. Wheeldon for the MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators
Circulation published July 15, 2002, doi:10.1161/01.CIR.0000024416.33113.0A
[Abstract]
- Articles
Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells
- Massimo Federici, Rossella Menghini, Alessandro Mauriello, Marta Letizia Hribal, Francesca Ferrelli, Davide Lauro, Paolo Sbraccia, Luigi Giusto Spagnoli, Giorgio Sesti, and Renato Lauro
Circulation published July 8, 2002, doi:10.1161/01.CIR.0000023043.02648.51
[Abstract]
- Articles
Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C--Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure
- Peter Razeghi, Martin E. Young, Tonya C. Cockrill, O. Howard Frazier, and Heinrich Taegtmeyer
Circulation published July 1, 2002, doi:10.1161/01.CIR.0000026392.80723.DC
[Abstract]
- Current Perspectives
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease
- Robert H. Eckel, Winifred W. Barouch, and Abby G. Ershow
Circulation 2002;105:2923-2928, doi:10.1161/01.CIR.0000017823.53114.4C
[Full text]
- Clinical Investigations and Reports
Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up
- Marco Roffi, David J. Moliterno, Bernhard Meier, Eric R. Powers, Cindy L. Grines, Peter M. DiBattiste, Howard C. Herrmann, Michel Bertrand, Katherine E. Harris, Laura A. Demopoulos, Eric J. Topol for the TARGET Investigators*
Circulation 2002;105:2730-2736; published online before print as doi:10.1161/01.CIR.0000018123.02672.C7
[Abstract]
[Full text]
- Cardiology Patient Pages
Restenosis: Repeat Narrowing of a Coronary Artery: Prevention and Treatment
- George Dangas and Frank Kuepper
Circulation 2002;105:2586-2587, doi:10.1161/01.CIR.0000019122.00032.DF
[Full text]
- Clinician Update
Evaluation and Treatment of Patients With Systemic Hypertension
- Jay Garg, Adrian W. Messerli, and George L. Bakris
Circulation 2002;105:2458-2461, doi:10.1161/01.CIR.0000017143.59204.AA
[Full text]
- Articles
Impact of Different Platelet
Glycoprotein IIb/IIIa Receptor Inhibitors Among
Diabetic Patients Undergoing Percutaneous
Coronary Intervention. Do Tirofiban and ReoPro Give Similar
Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up
- Marco Roffi, David J. Moliterno, Bernhard Meier, Eric R. Powers, Cindy L. Grines, Peter M. DiBattiste, Howard C. Herrmann, Michel Bertrand, Katherine E. Harris, Laura A. Demopoulos, Eric J. Topol for the TARGET
Investigators
Circulation published May 13, 2002, doi:10.1161/01.CIR.0000018123.02672.C7
[Abstract]
- AHA Conference Proceedings
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
- Barbara V. Howard, Beatriz L. Rodriguez, Peter H. Bennett, Maureen I. Harris, Richard Hamman, Lewis H. Kuller, Thomas A. Pearson, and Judith Wylie-Rosett
Circulation 2002;105:e132-137e, doi:10.1161/01.CIR.0000013953.41667.09
[Full text]
- AHA Conference Proceedings
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes
- Robert H. Eckel, Momtaz Wassef, Alan Chait, Burton Sobel, Eugene Barrett, George King, Maria Lopes-Virella, Jane Reusch, Neil Ruderman, George Steiner, and Helen Vlassara
Circulation 2002;105:e138-143e, doi:10.1161/01.CIR.0000013954.65303.C5
[Full text]
|
|
